HuGE Literature Finder
Records 1-30
|
Rare germline variants in DNA repair-related genes are accountable for papillary thyroid cancer susceptibility.
Endocrine 2021 Apr . Mio Catia, Verrienti Antonella, Pecce Valeria, Sponziello Marialuisa, Damante Giusep |
|
Comprehensive evaluation of risk factors for lymph node metastasis in patients with papillary thyroid carcinoma.
Oncology letters 2021 Mar 21 (3): 188. Dong Yan, Wang Dan, Luo Yisheng, Chen Ling, Bai Huili, Shen Yifan, Zhang Yangli, Chen Xueping, Su Xinliang, Zhao Jinqiu, Liu Huandong, Lu Jungao, Yao Zuoyi, Zhao Yajing, He Changlong, Li Xiaoso |
|
Clinical Utility of Circulating Cell-free DNA Mutations in Anaplastic Thyroid Carcinoma.
Thyroid : official journal of the American Thyroid Association 2021 Feb . Qin Y U, Wang Jennifer Rui, Wang Ying, Iyer Priyanka C, Cote Gilbert, Busaidy Naifa, Dadu Ramona, Zafereo Mark, Williams Michelle D, Ferrarotto Renata, Gunn Brandon, Wei Peng, Patel Keyur, Hofmann Marie-Claude, Cabanillas Mar |
|
Papillary Thyroid Carcinoma in Patients with Acromegaly from a Single Center in China.
World neurosurgery 2021 Feb . Zhao Yang, Wang Yuanyuan, Zhang Xue, Jia Nan, Ma Zhuoqun, Fu Jiao, Liu S |
|
Novel recurrent altered genes in Chinese patients with anaplastic thyroid cancer.
The Journal of clinical endocrinology and metabolism 2021 Jan . Zhang Lingyun, Ren Zhixiang, Su Zhengzheng, Liu Yang, Yang Tian, Cao Minyuan, Jiang Yong, Tang Ying, Chen Haining, Zhang Weihan, Gong Rixiang, Wei Tao, Peng Yong, Liu Bo, Zhang Wei, Yang Li, Hu Yiguo, Li Zhihui, Zhu Jingqiang, Xu Heng, Shu Yang, Luo H |
|
Analysis of the expression and potential molecular mechanism of interleukin-1 receptor antagonist (IL1RN) in papillary thyroid cancer via bioinformatics methods.
BMC cancer 2020 Nov 20 (1): 1143. Xie Zhenyu, Li Xin, He Yuzhen, Wu Song, Wang Shiyue, Sun Jianjian, He Yuchen, Lun Yu, Xin Shijie, Zhang Ji |
|
The mutation profile of differentiated thyroid cancer coexisting with undifferentiated anaplastic cancer resembles that of anaplastic thyroid cancer but not that of archetypal differentiated thyroid cancer.
Journal of applied genetics 2020 Nov . Mika Justyna, Labaj Wojciech, Chekan Mykola, Abramowicz Agata, Pietrowska Monika, Polanski Andrzej, Widlak Pio |
|
Molecular characterisation and clinical correlation of papillary thyroid microcarcinoma.
Endocrine 2020 Jul . Samà Maria Teresa, Grosso Enrico, Mele Chiara, Laurora Sara, Monzeglio Oriana, Marzullo Paolo, Boldorini Renzo, Aluffi Valletti Paolo, Aimaretti Gianluca, Scatolini Maria, Pagano Loreda |
|
[The possibility of using freely circulating DNA blood plasma in preoperative diagnosis of thyroid tumors].
Problemy endokrinologii 2020 Jun 65 (6): 400-407. Kachko Vera A, Vanushko Vladimir E, Platonova Nadezhda M, Abrosimov Aleksandr Yu, Tely Sheva Ekaterina N, Snigireva Galina |
|
Evaluation of the expression levels of BRAF
BMC cancer 2020 May 20 (1): 368. Tran Tien Viet, Dang Kien Xuan, Pham Quynh Huong, Nguyen Ung Dinh, Trinh Nhung Thi Trang, Hoang Luong Van, Ho Son Anh, Nguyen Ba Van, Nguyen Duc Trong, Trinh Dung Tuan, Tran Dung Ngoc, Orpana Arto, Stenman Ulf-Håkan, Stenman Jakob, Ho Tho H |
|
BRAF
World journal of surgery 2020 Apr . Enumah Samuel, Fingeret Abbey, Parangi Sareh, Dias-Santagata Dora, Sadow Peter M, Lubitz Carrie |
|
Risk stratification using a novel genetic classifier including <i>PLEKHS1</i> promoter mutations for differentiated thyroid cancer with distant metastasis.
Thyroid : official journal of the American Thyroid Association 2020 Apr . Jung Chan Kwon, Jung Seung-Hyun, Jeon Sora, Jeong Young Mun, Kim Yourha, Lee Sohee, Bae Ja-Seong, Chung Yeun-Ju |
|
The relation between BRAFV600E mutation and clinicopathological characteristics of papillary thyroid cancer.
Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina 2020 Feb 17 (1): . Celik Mehmet, Bulbul Buket Yilmaz, Ayturk Semra, Durmus Yusuf, Gurkan Hakan, Can Nuray, Tastekin Ebru, Ustun Funda, Sezer Atakan, Guldiken Sib |
|
Detection of ctDNA in the plasma of patients with papillary thyroid carcinoma.
Experimental and therapeutic medicine 2019 Nov 18 (5): 3389-3396. Li Huiqiang, Zhao Jiangman, Zhang Jianhua, Wang Congren, Li Mingzhu, Wu Shouxin, Su Zijian, Pan Qunxio |
|
Next-generation sequencing identified somatic alterations that may underlie the etiology of Chinese papillary thyroid carcinoma.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2019 Nov . Yang Chuanjia, Gong Jian, Xu Weixue, Liu Zhen, Cui Dong |
|
TSHR rs2288496 associated with thyroid hormone and predict the occurrence of lymph node metastasis of papillary thyroid cancer.
Cancer biomarkers : section A of Disease markers 2019 Oct . Su Xuan, Lin Li-Wen, Weng Jie-Ling, Chen Shu-Wei, Yang Xin-Hua, Zhou Da-Lei, Long Ya-Kang, Shao Qiong, Ye Zu-Lu, Peng Jun-Ling, Deng Ling, He Cai-Yun, Yang An-K |
|
Analysis of Biomarkers and Association With Clinical Outcomes in Patients With Differentiated Thyroid Cancer: Subanalysis of the Sorafenib Phase 3 DECISION Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2019 Sep . Brose Marcia S, Schlumbeger Martin, Jeffers Michael, Kappeler Christian, Meinhardt Gerold, Peña Carol |
|
BRAF and TERT mutations in papillary thyroid cancer patients of Latino ancestry.
Endocrine connections 2019 Aug . Estrada-Florez Ana Patricia, Bohorquez Mabel, Velez Alejandro, Duque Carlos Simon, Donado Jorge, Mateus Gilbert, Panqueba-Tarazona Cesar, Polanco-Echeverry Guadalupe, Sahasrabudhe Ruta M, Echeverry Magdalena, Carvajal-Carmona Luis |
|
The Genetic Duet of BRAF V600E and TERT Promoter Mutations Robustly Predicts the Loss of Radioiodine Avidity in Recurrent Papillary Thyroid Cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2019 Aug . Liu Jiajun, Liu Rengyun, Shen Xiaopei, Zhu Guangwu, Li Biao, Xing Mingzh |
|
Impact of BRAF V600E and TERT promoter mutations on response to therapy in papillary thyroid cancer.
Endocrinology 2019 Jul . Trybek Tomasz, Walczyk Agnieszka, Gasior-Perczak Danuta, Palyga Iwona, Mikina Estera, Kowalik Artur, Hincza Kinga, Kopczynski Janusz, Chrapek Magdalena, Gózdz Stanislaw, Kowalska Aldo |
|
Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China.
Diagnostic pathology 2019 Jul 14 (1): 74. Huang Meiling, Yan Changjiao, Xiao Jingjing, Wang Ting, Ling R |
|
Mutational profiling of poorly differentiated and anaplastic thyroid cancer by targeted next-generation sequencing.
Histopathology 2019 Jun . Duan Huanli, Li Yan, Hu Peizhen, Gao Jie, Ying Jianming, Xu Wanni, Zhao Danhui, Wang Zhe, Ye Junyi, Lizaso Analyn, Wu Huanwen, Liang Zhiyo |
|
Mutation profiles of follicular thyroid tumors by targeted sequencing.
Diagnostic pathology 2019 May 14 (1): 39. Duan Huanli, Liu Xiaoding, Ren Xinyu, Zhang Hui, Wu Huanwen, Liang Zhiyo |
|
Somatic genetic alterations in a large cohort of pediatric thyroid nodules.
Endocrine connections 2019 May . Pekova Barbora, Dvorakova Sarka, Sykorova Vlasta, Vacinova Gabriela, Vaclavikova Eliska, Moravcova Jitka, Katra Rami, Vlcek Petr, Sykorova Pavla, Kodetova Daniela, Vcelák Josef, Bendlova Be |
|
Effect of Sentinel Node Biopsy in Clinically N0, BRAF V600E-Mutated, Small Papillary Thyroid Carcinoma: A Pilot Study.
Clinical nuclear medicine 2019 Jan . Puccini Marco, Manca Gianpiero, Neri Carlo Maria, Boni Giuseppe, Coli Virginia, Garau Ludovico Maria, Colletti Patrick M, Rubello Domenico, Buccianti Pie |
|
TERT promoter mutations identify a high-risk group in metastasis-free advanced thyroid carcinoma.
European journal of cancer (Oxford, England : 1990) 2019 Jan 108 41-49. Bournaud Claire, Descotes Françoise, Decaussin-Petrucci Myriam, Berthiller Julien, de la Fouchardière Christelle, Giraudet Anne-Laure, Bertholon-Gregoire Mireille, Robinson Philip, Lifante Jean-Christophe, Lopez Jonathan, Borson-Chazot Françoi |
|
Thyroid Carcinoma Coexisting with Hashimoto's Thyreoiditis: Clinicopathological and Molecular Characteristics Clue up Pathogenesis.
Pathology oncology research : POR 2019 Jan . Molnár Csaba, Molnár Sarolta, Bedekovics Judit, Mokánszki Attila, Gyory Ferenc, Nagy Endre, Méhes Gáb |
|
Lysyl Oxidase Is a Key Player in BRAF/MAPK Pathway-Driven Thyroid Cancer Aggressiveness.
Thyroid : official journal of the American Thyroid Association 2019 01 29 (1): 79-92. Boufraqech Myriem, Patel Dhaval, Nilubol Naris, Powers Astin, King Timothy, Shell Jasmine, Lack Justin, Zhang Lisa, Gara Sudheer Kumar, Gunda Viswanath, Klubo-Gwiezdzinska Joanna, Kumar Suresh, Fagin James, Knauf Jeffrey, Parangi Sareh, Venzon David, Quezado Martha, Kebebew Electr |
|
BRAF Mutation in Papillary Thyroid cancer - prevalence and clinical correlation in a Southeast Asian cohort.
Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery 2018 Oct . Goh Xueying, Lum Jeffery, Yang Samantha Peiling, Chionh Siok Bee, Koay Evelyn, Chiu Lily, Parameswaran Rajeev, Ngiam Kee Yuan, Loh Thomas Kwok Seng, Nga Min En, Lim Chwee Mi |
|
Low Prevalence of TERT Promoter, BRAF and RAS Mutations in Papillary Thyroid Cancer in the Greek Population.
Pathology oncology research : POR 2018 Oct . Argyropoulou Marilena, Veskoukis Aristidis S, Karanatsiou Pagona-Maria, Manolakelli Aikaterini, Kostoglou-Athanassiou Ifigenia, Vilaras George, Karameris Andreas, Liadaki Kallio |
- Page last reviewed:Oct 1, 2020
- Page last updated:May 05, 2021
- Content source: